ArriVent BioPharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ArriVent BioPharma, Inc.
CIK #0001868279
EDGAR Form CIK 2011 - 2024
10-K [0001868279]
10-Q [0001868279]
3 [0001868279]
4 [0001868279]
8-K [0001868279]
D [0001868279]
SC 13D [0001868279]
SC 13G [0001868279]
Form 13D/13G Filer Form 13D/13G Subject Filed
LAV Fund VI LP Arrivent Biopharma Inc [2024-02-13]
OrbiMed Advisors LLC Arrivent Biopharma Inc [2024-02-05]
Form 3/4/5 Subject 2011 - 2024
LaChapelle Robin
ArriVent BioPharma, Inc.
Hohneker John
Peterson Kristine
HHLR Advisors Ltd
Hillhouse Investment Management Ltd
OrbiMed Asia GP IV, L.P.
OrbiMed Advisors LLC
OrbiMed Advisors IV Ltd
OrbiMed Capital GP VIII LLC
View All
Terms | Privacy | Guide
tony@aum13f.com